Palatin Technologies Inc. (PTN) |
|
0.4783 -0.02 (-4.03%)
|
07-02 16:00 |
|
Open: |
0.49 |
Pre. Close: |
0.4984 |
|
High:
|
0.51 |
Low:
|
0.4722 |
|
Volume:
|
2,470,832 |
Market Cap:
|
110M |
|
|
|
|
Palatin Technologies, Inc., a specialized biopharmaceutical company, develops targeted receptor-specific product candidates for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor agonist, which has completed Phase III trial for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder. It is also developing oral PL8177, a selective melanocortin receptor 1 (MCr) agonist peptide that has completed Phase I clinical trial for inflammatory bowel diseases; and systemic PL8177, which has completed Phase I clinical trial for treating non-infectious uveitis. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.511 - 0.515 |
0.515 - 0.518 |
|
Low:
|
0.462 - 0.466 |
0.466 - 0.469 |
|
Close:
|
0.474 - 0.481 |
0.481 - 0.486 |
|
Technical analysis |
as of: 2020-07-02 4:33:39 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 0.75  One year: 0.86 |
| Support: |
Support1: 0.47 Support2: 0.40 |
| Resistance: |
Resistance1: 0.64 Resistance2: 0.74 |
| Pivot: |
0.54 |
| Moving Average: |
MA(5): 0.51 MA(20): 0.57
MA(100): 0.50 MA(250): 0.70 |
| MACD: |
MACD(12,26): -0.01 Signal(9): 0.01 |
| Stochastic oscillator: |
%K(14,3): 8.43 %D(3): 12.83 |
| RSI: |
RSI(14): 42.67 |
| 52-week: |
High: 1.13 Low: 0.36 Change(%): -50.2 |
| Average Vol(K): |
3-Month: 247855 10-Days: 650938 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.PTN has closed above bottom band by 13.8%. Bollinger Bands are 23.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Tue, 30 Jun 2020
Why Buy stock in Palatin Technologies, Inc. (PTN)? - Marketing Sentinel
Mon, 29 Jun 2020
Palatin Technologies Announces Adjournment of Annual Meeting of Stockholders - Yahoo Finance
Thu, 25 Jun 2020
Edited Transcript of PTN.A earnings conference call or presentation 12-May-20 3:00pm GMT - Yahoo Finance
Wed, 24 Jun 2020
Palatin Technologies, Inc. (PTN) Worth Considering For The Next Few Weeks - Stocks Register
Wed, 24 Jun 2020
Palatin Technologies, Inc. (NYSE:PTN) 17.84% up over a week, Can The Stock Hit well above $0.7? - Marketing Sentinel
Tue, 23 Jun 2020
Analyst Rating: Will Palatin Technologies, Inc. (PTN) Stock Outperform the Market? - InvestorsObserver
|
Financial Analysis |
| Growth |
|
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NYSE American |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
229 |
| Shares Float (M) |
212 |
|
% Held by Insiders
|
3.33 |
|
% Held by Institutions
|
22.79 |
|
Shares Short (K)
|
21,160 |
|
Shares Short P. Month (K)
|
18,480 |
Stock Financials |
|
EPS
|
0.151 |
|
EPS Est This Year
|
-0.350 |
|
EPS Est Next Year
|
-0.060 |
|
Book Value (p.s.)
|
0.380 |
|
Profit Margin
|
61.44 |
|
Operating Margin
|
59.57 |
|
Return on Assets (ttm)
|
40.5 |
|
Return on Equity (ttm)
|
72.2 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
0.198 |
|
Sales Per Share
|
0.263 |
|
EBITDA (p.s.)
|
0.157 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
40 |
|
Levered Free Cash Flow (M)
|
25 |
Stock Valuations |
|
PE Ratio
|
3.17 |
|
PEG Ratio
|
|
|
Price to Book value
|
1.26 |
|
Price to Sales
|
1.82 |
|
Price to Cash Flow
|
2.71 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
